Skip to Main Content

Paper Details

<i>PITX3</i> promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy.
Clin Epigenetics
15
2016
Author NameAffiliation
Verena SailerWeill Cornell Medicine of Cornell University
Verena SailerEnglander Institute for Precision Medicine, Weill Cornell Medicine of Cornell University
  • 1 - 2

Datasets

Release 1.2